Merck announced promising trial results this week, but the full data has yet to be released.
from Livescience.com https://ift.tt/3Fk45YX
via IFTTT
Jumat, 01 Oktober 2021
Home »
IFTTT
,
LiveScience.com
» New antiviral pill halves risk of COVID-19 hospitalization, Merck says
0 komentar:
Posting Komentar